Zobrazeno 1 - 4
of 4
pro vyhledávání: '"pi3kα-inhibitors"'
Autor:
Sabbah Dima A., Al-Azaideh Bara’a A., Talib Wamidh H., Hajjo Rima, Sweidan Kamal, Al-Zuheiri Aya M., Sheikha Ghassan Abu, Shraim Sawsan
Publikováno v:
Acta Pharmaceutica, Vol 71, Iss 4, Pp 545-565 (2021)
Phosphoinositide 3-kinase α (PI3Kα) is a propitious target for designing anticancer drugs. A series of new N’-(diphenylmethylene)benzenesulfonohydrazide was synthesized and characterized using FT-IR, NMR (1H and 13C), HRMS, and elemental analysis
Externí odkaz:
https://doaj.org/article/73a2b2a187bf44e68ccc2f1a964cb57c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kamal Sweidan, Ghassan Abu Sheikha, Sawsan Shraim, Bara’a A. Al-Azaideh, Wamidh H. Talib, Rima Hajjo, Aya M. Al-Zuheiri, Dima A. Sabbah
Publikováno v:
Acta Pharmaceutica, Vol 71, Iss 4, Pp 545-565 (2021)
Phosphoinositide 3-kinase α (PI3Kα) is a propitious target for designing anticancer drugs. A series of new N’-(diphenylmethylene)benzenesulfonohydrazide was synthesized and characterized using FT-IR, NMR (1H and 13C), HRMS, and elemental analysis
Autor:
DIMA A. SABBAH, BARA’A A. AL-AZAIDEH, WAMIDH H. TALIB, RIMA HAJJO, KAMAL SWEIDAN, AYA M. AL-ZUHEIRI, GHASSAN ABU SHEIKHA, SAWSAN SHRAIM
Publikováno v:
Acta Pharmaceutica
Volume 71
Issue 4
Volume 71
Issue 4
Phosphoinositide 3-kinase α (PI3Kα) is a propitious target for designing anticancer drugs. A series of new N'-(diphenylmethylene)benzenesulfonohydrazide was synthesized and characterized using FT-IR, NMR (1H and 13C), HRMS, and elemental analysis.